AUTOIMMUNE HEMOLYTIC ANEMIA, AIHA
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA, AIHA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA, AIHA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, AIHA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to help patients with rare blood disease stop steroids
Disease control Not yet recruitingThis study looks at whether adding sirolimus to standard steroid treatment helps adults with newly diagnosed mild autoimmune hemolytic anemia (AIHA) achieve long-term remission without needing ongoing medication. About 216 participants will be randomly assigned to receive either …
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA, AIHA
Phase: NA • Sponsor: Chen Miao • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New pill offers hope for patients with stubborn blood-destroying disease
Disease control Not yet recruitingThis study tests a daily oral drug called orelabrutinib in 50 adults with autoimmune hemolytic anemia (AIHA) that has not responded to standard treatments. The goal is to see if the drug can control the disease by stopping the immune system from destroying red blood cells. Partic…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA, AIHA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC